News & Alerts
-
Sep- 2023 -11 September
The Enigma of Analgesics in Low Back Pain Management: Safety and Efficacy Questions
Despite decades of research, the effectiveness and safety of analgesic medications for treating acute low back pain remain uncertain, according…
Read More » -
11 September
Abdominal Fat’s Surprising Effect on Brain Volume in Middle Age – Study
New research has unveiled compelling evidence linking abdominal fat to reduced brain volumes, especially those regions responsible for cognitive function.…
Read More » -
8 September
Report Reveals Californian Pharmacists Commit 5 Million Errors Annually
The California Board of Pharmacy’s recent findings shed light on a concerning issue within the pharmaceutical industry: overworked and understaffed…
Read More » -
6 September
FDA Unveils Innovative Strategy to Tackle Drug Shortages Through Quality Management
As quality-related issues persist as the predominant cause behind drug shortages, the Food and Drug Administration (FDA) has unveiled a…
Read More » -
6 September
WEFUN Inc. Issues Voluntary Nationwide Recall of WEFUN Capsules Due to Presence of Undeclared Sildenafil
Brooklyn, New York, September 5, 2023 – WEFUN Inc., a dietary supplement manufacturer, has initiated a voluntary nationwide recall of…
Read More » -
6 September
The Emergence of Ultra-Potent Synthetic Opioid ‘Nitazenes’ Raises Alarming Concerns Amidst Opioid Crisis
In recent times, the opioid crisis has been further exacerbated by the appearance of illicit street fentanyl, a bootleg variant…
Read More » -
6 September
How to Use Telehealth Services to Access Medical Abortion
Telehealth services, also known as telemedicine or virtual healthcare, refer to the use of telecommunications technology to provide medical and…
Read More » -
5 September
UK Court Greenlights Legal Action Against Bayer Over Essure Contraceptive Device
Women in the United Kingdom who have reported harm from using Bayer’s Essure contraceptive device have received approval to pursue…
Read More » -
5 September
Amgen and FTC Reach Accord, Paving the Path for $28 Billion Horizon Deal
Amgen’s $28 billion acquisition of Horizon Pharma has overcome a significant obstacle with the resolution of its dispute with the…
Read More » -
5 September
List Of Top 20 Rare Diseases and Their Symptoms
A rare disease, colloquially referred to as an orphan disease, represents a medical conundrum that plagues a relatively minuscule fraction…
Read More »